Bss plus and Corneal opacity - a phase IV clinical study of FDA data

Summary:

Corneal opacity is reported as a side effect among people who take Bss plus (calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate), especially for people who are male, 60+ old, have been taking the drug for < 1 month and have Mydriasis.

The phase IV clinical study analyzes which people have Corneal opacity when taking Bss plus. It is created by eHealthMe based on reports of 286 people who have side effects when taking Bss plus from the FDA, and is updated regularly.

What is Bss plus?

Bss plus has active ingredients of calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate. eHealthMe is studying from 288 Bss plus users. Check the latest studies of Bss plus.

What is Corneal opacity?

Corneal opacity (scarring or clouding of the cornea) is found to be associated with 126 drugs and 315 conditions by eHealthMe. Check the latest studies of Corneal opacity.

On Aug, 01, 2026

286 people reported to have side effects when taking Bss plus.
Among them, 13 people (4.55%) have Corneal opacity.

Among these 13 people:

How long have people been on Bss plus when they have Corneal opacity? *

What is the gender of people who have Corneal opacity when taking Bss plus? *

female: 0.0 %
male: 100 %

What is the age of people who have Corneal opacity when taking Bss plus? *

What are other side effects people have besides Corneal opacity? *

Corneal Oedema (corneal swelling): 4 people, 30.77%
Corneal Disorder: 3 people, 23.08%
Visual Acuity Reduced (reduced clearness of vision): 2 people, 15.38%
Posterior Capsule Rupture (tear in the posterior capsule identified at the time of surgery): 2 people, 15.38%
Corneal Degeneration (abnormal deposition of substances in the transparent front part of the eye): 2 people, 15.38%
Retinal Exudates (discharge from retina): 1 person, 7.69%
Post Procedural Infection: 1 person, 7.69%
Inflammation: 1 person, 7.69%
Hypopyon (pus in the eye): 1 person, 7.69%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 1 person, 7.69%

What are the existing conditions these people have? *

Mydriasis (a dilation of the pupil): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Bss plus and have Corneal opacity?

- Check whether Corneal opacity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bss plus:

Bss plus (288 reports)

Corneal opacity treatments and more:

Corneal opacity (1,595 reports)

How severe was Corneal opacity and when was it recovered:

Corneal opacity in Bss plus

Expand to all the drugs that have ingredients of calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate:

Corneal opacity and drugs with ingredients of calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bss plus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Corneal opacity:

Corneal opacity (126 drugs)

Browse all the conditions that are associated with Corneal opacity:

Corneal opacity (315 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate (the active ingredients of Bss plus) and Bss plus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.